MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM

Clinical trials for MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM trials appear

Sign up with your email to follow new studies for MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 6 Completed 1

New hope for rare blood cancers? immune therapy trial seeks to tame disease

Disease control Not yet recruiting

This study is testing a long-acting immune therapy drug called ropeginterferon alfa-2b for adults with rare, overlapping blood cancers like chronic myelomonocytic leukemia (CMML). The main goals are to find a safe and effective dose and to see if the drug can control the disease …

Matched conditions: MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM

Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM

Get alerted when new MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM trials appear

New hope for rare blood cancers? immune therapy trial seeks to tame disease